Advertisement
Screener

Elicio Therapeutics, Inc. (ELTX) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

Elicio Therapeutics, Inc. Cash Flow Breakdown

Cash flow breakdown shows where Elicio Therapeutics, Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $36.95M went out.
  • Fiscal year ended 2025-12-31: from investing, $16.00K went out.
  • Fiscal year ended 2025-12-31: from financing, $36.70M came in.
  • Fiscal year ended 2025-12-31: change in cash, $225.00K went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingBuybacksNew debtStaff share taxNew shares soldNot split outChange in cash
2025-12-31-$36.95M-$16.00K$0.00$16.24M$20.45M*-$225.00K
2024-12-31-$37.07M-$84.00K$0.00$19.73M$4.55M$18.04M*$5.19M
2023-12-31-$32.69M-$32.00K-$150.00K$0.00$7.00M$31.76M*$5.89M
2022-12-31-$22.18M-$654.00K$0.00$82.00K$21.12M*-$1.63M
2021-12-31-$52.64M-$382.00K-$2.46M*$107.49M$54.15M
2020-12-31-$22.89M-$41.00K-$36.00K-$522.00K$52.97M*$29.04M

Each quarter (3 month)

Quarter endRunning the businessFrom investingBuybacksNew debtStaff share taxNew shares soldNot split outChange in cash
2026-06-30-$8.16M*$17.00K*$16.49M*
2026-03-31-$11.64M$100.00K$7.93M*-$3.61M
2025-12-31-$6.80M*-$16.00K*$0.00*$4.00K*$4.86M*
2025-09-30-$11.09M*$0.00*$88.00K*$9.48M*
2025-06-30-$8.95M*$0.00*$2.02M*$9.92M*
2025-03-31-$10.12M$0.00$835.00K$9.49M*$240.00K
2024-12-31-$8.74M*-$45.00K*$0.00*$0.00*-$858.00K*
2024-09-30-$7.27M*$0.00*$0.00*$48.00K*$30.71M*
2024-06-30-$8.93M*-$42.00K*$303.00K*
2024-03-31-$12.12M$3.00K$5.06M$5.96M*-$1.09M
2023-12-31-$9.89M*$0.00*$0.00*$7.00M*
2023-09-30-$5.18M*-$45.00K*$0.00*$0.00*
2023-06-30-$9.47M*$30.00K*$0.00*$21.51M*
2023-03-31-$8.14M-$17.00K$0.00$10.04M*$1.88M
2022-12-31-$7.28M*-$95.00K*$0.00*$2.00K*$65.00K*$11.11M*
2022-09-30-$5.39M*$0.00*$0.00*-$2.00K*$0.00*$8.78M*
2022-06-30$6.14M*-$559.00K*$0.00*$78.00K*$1.18M*
2022-03-31-$15.65M$0.00$0.00$0.00-$15.75M
2021-12-31-$14.36M*-$36.00K*$0.00*-$3.07M*
2021-09-30-$15.20M*-$61.00K*-$94.00K*$0.00*$793.00K*
2021-06-30-$10.53M*-$244.00K*-$1.22M*$0.00*-$1.16M*
2021-03-31-$12.55M-$41.00K-$1.15M$110.56M-$971.00K*$95.85M
2020-12-31$20.59M*-$10.00K*-$36.00K*-$522.00K*
2020-09-30-$21.94M*-$1.00K*$0.00*$0.00*$31.22M*
2020-06-30-$12.80M*-$10.00K*$0.00*$0.00*$17.05M*
2020-03-31-$8.73M-$20.00K$0.00$0.00$3.94M*-$4.58M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Lite Strategy, Inc. (LITS)United States$0.049B
Dogwood Therapeutics, Inc. (DWTX)United States$0.049B
Werewolf Therapeutics, Inc. (HOWL)United States$0.047B
Xilio Therapeutics, Inc. (XLO)United States$0.052B
Grace Therapeutics, Inc. (GRCE)$0.046B-1.83
PDS Biotechnology Corp (PDSB)United States$0.045B
SCYNEXIS INC (SCYX)United States$0.045B
Serina Therapeutics, Inc. (SER)United States$0.054B-2.35
Clene Inc. (CLNN)United States$0.054B-1.99
HERON THERAPEUTICS, INC. /DE/ (HRTX)United States$0.055B-2.38